KRYS
Krystal Biotech IncNASDAQHEALTHCAREBIOTECHNOLOGY
Key Statistics
Market Cap
$9.01B
P/E Ratio
40.98
EPS
$7.46
Beta
0.49
52W High
$306.10
52W Low
$122.80
50-Day MA
$264.04
200-Day MA
$221.29
Dividend Yield
—
Profit Margin
53.90%
Forward P/E
44.84
PEG Ratio
—
About Krystal Biotech Inc
Krystal Biotech, Inc., a clinical-stage biotechnology company, is dedicated to the field of redosable gene therapy to treat serious rare diseases in the United States. The company is headquartered in Pittsburgh, Pennsylvania.
Fundamentals
| Revenue (TTM) | $417.30M |
| Gross Profit (TTM) | $392.96M |
| EBITDA | $180.47M |
| Operating Margin | 46.10% |
| Return on Equity | 19.90% |
| Return on Assets | 9.04% |
| Revenue/Share (TTM) | $14.36 |
| Book Value | $41.78 |
| Price-to-Book | 7.06 |
| Price-to-Sales (TTM) | 21.60 |
| EV/Revenue | 19.66 |
| EV/EBITDA | 44.25 |
| Quarterly Earnings Growth (YoY) | 52.50% |
| Quarterly Revenue Growth (YoY) | 31.90% |
| Shares Outstanding | $29.48M |
| Float | $23.37M |
| % Insiders | 11.22% |
| % Institutions | 105.90% |
Historical Volatility
HV 10-Day
47.29%
HV 20-Day
40.41%
HV 30-Day
36.97%
HV 60-Day
41.08%
HV Rank
41.3%
Volatility is currently expanding
Analyst Ratings
Consensus ($318.22 target)
10
Buy1
HoldMore HEALTHCARE Stocks
Data last updated: 5/11/2026